0001437749-24-004359.txt : 20240215
0001437749-24-004359.hdr.sgml : 20240215
20240215161641
ACCESSION NUMBER: 0001437749-24-004359
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240213
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAIER PAUL V
CENTRAL INDEX KEY: 0001182615
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38738
FILM NUMBER: 24644024
MAIL ADDRESS:
STREET 1: 3595 JOHN HOPKINS COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001710340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 371858472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7278
BUSINESS PHONE: (847) 787-7361
MAIL ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7278
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-02-13
0001710340
Eton Pharmaceuticals, Inc.
ETON
0001182615
MAIER PAUL V
C/O ETON PHARMACEUTICALS, INC.
21925 W. FIELD PARKWAY, SUITE 235
DEERPARK
IL
60010-7208
1
0
Stock Option (Right to buy)
4.42
2024-02-13
4
A
0
30000
0
A
2034-02-12
Common Stock
30000
164555
D
The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 13, 2025.
The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.
/s/ James R. Gruber
2024-02-15